Skip to content
Menu

Head-to-head comparison

LIV by WellNow vs Vytora Health

Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.

Ranked #164
LIV by WellNow

LIV by WellNow is the telehealth weight-management arm of WellNow Urgent Care, offering compounded semaglutide at $195/month for the average dose — medication, supplies and unlimited virtual visits included — from a named pharmacy.

From $195/mo (lowest dose rung) sema · Verified August 2026

Marked down on: The price follows the DOSE: $195/month covers the average 1 mg dose, but 1.7 mg or 2.4 mg costs $265/month, and the headline says "no hidden fees"

vs
Ranked #12Desk pick
Vytora Health

Compounded semaglutide at $179 a month or $149 on a 3-month plan, tirzepatide at $249 or $199, plus brand Mounjaro and Zepbound at $1,399 a month — all-inclusive, no membership fee.

$179/mo sema · $249/mo tirz · Verified August 2026

Marked down on: Injectable only — no oral route

Vytora Health takes this head-to-head with the higher Desk Score, 89/100 (B+) against 71/100 (C) for LIV by WellNow. LIV by WellNow still holds its ground where its strengths line up with yours.

Desk Score, dimension by dimension

Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.

LIV by WellNow

71/100

C

Overall

Vytora Health

89/100

B+

Price transparency

94
90

State access

42
96

Molecule range

66
90

Onboarding speed

71
84

Support responsiveness

71
82

Licensing & trust

77
90

The spec sheet

FieldLIV by WellNowVytora Health
SemaglutideFrom $195/molowest dose rung$195/mo month-to-month (compounded, at the average 1 mg dose); $175/mo paid quarterly · higher doses of 1.7 mg or 2.4 mg are $265/mo, or $249/mo paid quarterly$179/mo$179/mo month-to-month; $149/mo on a 3-month plan ($447 every 3 months); same price at every dose; compounded injectable
TirzepatideNot listed on LIV by WellNow's site (checked August 2026)$249/mo$249/mo month-to-month; $199/mo on a 3-month plan ($599 every 3 months); same price at every dose; compounded injectable
Coverage5 states (IL, IN, MI, NY, PA)All 50 states and DC
Brand-nameYesYes
Oral optionInjectable onlyInjectable only
Best forPatients in IL, IN, MI, NY, or PA who want all-inclusive compounded semaglutide from a company with physical clinics behind it, and who have budgeted for the higher-dose rung.Someone who wants a low compounded price without prepaying a year, and the option to move to brand tirzepatide on the same account.
Desk Score71/100C89/100B+

The verdict

Desk pick — Vytora Health

Vytora Health takes this head-to-head with the higher Desk Score, 89/100 (B+) against 71/100 (C) for LIV by WellNow. LIV by WellNow still holds its ground where its strengths line up with yours.

Choose LIV by WellNow if…

Patients in IL, IN, MI, NY, or PA who want all-inclusive compounded semaglutide from a company with physical clinics behind it, and who have budgeted for the higher-dose rung.

From $195/mo (lowest dose rung) sema · 5 states (IL, IN, MI, NY, PA)

Choose Vytora Health if…

Someone who wants a low compounded price without prepaying a year, and the option to move to brand tirzepatide on the same account.

$179/mo sema · $249/mo tirz · All 50 states and DC

Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: LIV by WellNow · Vytora Health.

Also here

CoreAge Rx leads the whole ranking at 94/100

Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.